influenza%20(pediatric)
INFLUENZA (PEDIATRIC)
Influenza may present as a mild respiratory illness similar to the common cold or it may present without characteristic signs and symptoms.
The main type of influenza virus are types A, B & C virus. Types A&B are the main causes of influenza outbreaks.
Patient may appear flushed and have pain on eye movement. Non-exudative pharyngitis, scattered rales or rhonchi may be present.
Drug Information

Indication: Relief of mild to moderate pain & fever.

Indication: Prevention of flu in persons ≥65 yr; adults & childn w/ chronic pulmonary & CV disorders, chronic m...

Actimol Menstrual
pamabrom + paracetamol

Indication: Symptomatic relief of bloating, water-wt gain, backache, muscular aches, pre-menstrual & menstrual discomf...

Indication: Relief of fever associated w/ cold & flu, pain eg, teething, toothache, earache, sore throat, headache, mi...

Indication: Relief of unproductive or irritating coughs associated w/ common cold, sinusitis, flu & upper resp tract i...

Indication: Relief of fever & pain eg, headache, toothache, colds, flu, muscular rheumatism, dysmenorrhoea, teething p...

Indication: Relief of painful & febrile conditions eg, headache, migraine, backache, toothache, aches due to cold &...

Indication: Expectorant for symptomatic relief of cough due to colds & upper resp tract infections.

Indication: Relief of unproductive cough associated w/ common cold, sinusitis, flu & upper resp tract infection. Suita...

Indication: Relief of fever associated w/ cold & flu, pain eg, teething & toothache, earache, sore throats, headac...

1  /  9
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 27 Jun 2019

A 2-week course of the immunotherapy drug teplizumab delayed the onset of type 1 diabetes (T1D) in individuals at high risk for the condition, according to a phase II trial conducted by the TrialNet Study Group and presented at ADA 2019.